Unlearn Signs Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany to Accelerate Immunology Trials using Twintelligent RCTs™ February 16, 2022 San Francisco Biotechnology Network News News Comments Off on Unlearn Signs Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany to Accelerate Immunology Trials using Twintelligent RCTs™ SAN FRANCISCO--(BUSINESS WIRE)---- $MKKGY #AI--Collaborators will leverage AI-generated Digital Twins to enable smaller, more efficient pivotal clinical trials Click to view original post